ADVMAdverum Biotechnologies Inc

$4.49
$0.10
(2.35%)
Today
Closed $4.36
$0.13
(2.98%)
After Hours
Updated: 07:29 PM EST
Reported EarningsAug 12
Mkt Cap$96.26M
Vol1.02M

About

Adverum Biotechnologies, Inc. is a clinical-stage gene therapy company that engages in the development of gene therapies for ocular and rare diseases. The company was founded by Mark S. Blumenkranz, Thomas W. Chalberg, Jr., Mitchell H. Finer, and Steven Daniel Schwartz on July 17, 2006 and is headquartered in Redwood City, CA.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
N/A

Frequently Asked Questions

What is Market Cap of Adverum Biotechnologies Inc?
What is the 52-week high for Adverum Biotechnologies Inc?
What is the 52-week low for Adverum Biotechnologies Inc?
What is Adverum Biotechnologies Inc stock price today?
What was Adverum Biotechnologies Inc stock price yesterday?
What is the PE ratio of Adverum Biotechnologies Inc?
What is the Price-to-Book ratio of Adverum Biotechnologies Inc?
What is the 50-day moving average of Adverum Biotechnologies Inc?